8-[4-[(5-methyl-1H-pyrazol-3-yl)amino]thieno[3,2-d]pyrimidin-2-yl]-2,8-diazaspiro[4.5]decan-1-one
C18H21N7OS — CID 175894964
Data last refreshed: (MolForge compound catalog, from PubChem)
About 8-[4-[(5-methyl-1H-pyrazol-3-yl)amino]thieno[3,2-d]pyrimidin-2-yl]-2,8-diazaspiro[4.5]decan-1-one
8-[4-[(5-methyl-1H-pyrazol-3-yl)amino]thieno[3,2-d]pyrimidin-2-yl]-2,8-diazaspiro[4.5]decan-1-one (PubChem CID 175894964) has the molecular formula C18H21N7OS and a molecular weight of 383.48 g/mol. Its IUPAC name is 8-[4-[(5-methyl-1H-pyrazol-3-yl)amino]thieno[3,2-d]pyrimidin-2-yl]-2,8-diazaspiro[4.5]decan-1-one.
Molecular Properties
| Compound Name | 8-[4-[(5-methyl-1H-pyrazol-3-yl)amino]thieno[3,2-d]pyrimidin-2-yl]-2,8-diazaspiro[4.5]decan-1-one |
|---|---|
| PubChem CID | 175894964 |
| Molecular Formula | C18H21N7OS |
| Molecular Weight | 383.48 g/mol |
| Exact Mass | 383.15 |
| IUPAC Name | 8-[4-[(5-methyl-1H-pyrazol-3-yl)amino]thieno[3,2-d]pyrimidin-2-yl]-2,8-diazaspiro[4.5]decan-1-one |
| SMILES | Cc1cc(Nc2nc(N3CCC4(CCNC4=O)CC3)nc3ccsc23)n[nH]1 |
| InChI | InChI=1S/C18H21N7OS/c1-11-10-13(24-23-11)21-15-14-12(2-9-27-14)20-17(22-15)25-7-4-18(5-8-25)3-6-19-16(18)26/h2,9-10H,3-8H2,1H3,(H,19,26)(H2,20,21,22,23,24) |
| InChIKey | QWZBMEURMBLGFT-UHFFFAOYSA-N |
| XLogP | 2.57 |
| TPSA | 98.83 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 383.48 |
| LogP ≤ 5 | 2.57 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175894964 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.